Frontlight ResearchEarly access
Trial site
Hematology Hospital of the Chinese Academy of Medical Sciences
- 9running trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia2 trials
- Chronic lymphocytic leukaemia2 trials
- Acute lymphoblastic leukaemia1 trial
- Childhood cancers1 trial
- Diffuse large B-cell lymphoma1 trial
- Immune thrombocytopenia (ITP)1 trial
- Phase
- Phase 24 trials
- Phase 32 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 41 trial
- Status
- Recruiting6 trials
- Not yet recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Ascentage Pharma Group Inc.2 trials
- Beijing Yongtai Ruike Biotechnology Company Ltd2 trials
- Eli Lilly and Company2 trials
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 trial
- Daiichi Sankyo1 trial
- and 1 more
Running trials
Recruiting
Recruiting
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
Recruiting
Active, not recruiting
A Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients
Recruiting
Recruiting
A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
Recruiting
Recruiting
CAR-T-19 Injection in the Treatment of CD19-positive Relapsed/Refractory B-ALL
Recruiting
Phase I Clinical Trial of RC19D2 Cell Injection in the Treatment of Diffuse Large B-cell Lymphoma
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia2 recruiting
- Chronic lymphocytic leukaemia2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Immune thrombocytopenia (ITP)1 recruiting
Site data: ClinicalTrials.govUpdated 13 Nov 2026